{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:19:23Z","timestamp":1793963963697,"version":"4.8.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Loss of gut mucosal integrity and an aberrant gut microbiota are proposed mechanisms contributing to chronic inflammation and increased morbidity and mortality during antiretroviral-treated HIV disease. Sexual practice has recently been uncovered as a major source of microbiota variation, potentially confounding prior observations of gut microbiota alterations among persons with HIV (PWH). To overcome this and other confounding factors, we examine a well-powered subset of AGEhIV Cohort participants comprising antiretroviral-treated PWH and seronegative controls matched for age, body-mass index, sex, and sexual practice. We report significant gut microbiota differences in PWH regardless of sex and sexual practice including\n                    <jats:italic>Gammaproteobacteria<\/jats:italic>\n                    enrichment,\n                    <jats:italic>Lachnospiraceae<\/jats:italic>\n                    and\n                    <jats:italic>Ruminococcaceae<\/jats:italic>\n                    depletion, and decreased alpha diversity. Men who have sex with men (MSM) exhibit a distinct microbiota signature characterized by\n                    <jats:italic>Prevotella<\/jats:italic>\n                    enrichment and increased alpha diversity, which is linked with receptive anal intercourse in both males and females. Finally, the HIV-associated microbiota signature correlates with inflammatory markers including suPAR, nadir CD4 count, and prevalence of age-associated noncommunicable comorbidities.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-16222-8","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T06:05:00Z","timestamp":1589522700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":180,"title":["HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8611-4900","authenticated-orcid":false,"given":"I.","family":"Vujkovic-Cvijin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sortino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sklar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2066-8115","authenticated-orcid":false,"given":"F. W.","family":"Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Kootstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Brenchley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1369-3224","authenticated-orcid":false,"given":"J.","family":"Ananworanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Schim van der","family":"Loeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9962-3571","authenticated-orcid":false,"given":"Y.","family":"Belkaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7896-6428","authenticated-orcid":false,"given":"P.","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0076-0224","authenticated-orcid":false,"given":"I.","family":"Sereti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"16222_CR1","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cid\/ciu701","volume":"59","author":"J Schouten","year":"2014","unstructured":"Schouten, J. et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin. Infect. Dis. 59, 1787\u20131797 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"16222_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/imr.12064","volume":"254","author":"EM Wilson","year":"2013","unstructured":"Wilson, E. M. & Sereti, I. Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. Immunol. Rev. 254, 343\u2013354 (2013).","journal-title":"Immunol. Rev."},{"key":"16222_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12567","volume":"279","author":"JM Pickard","year":"2017","unstructured":"Pickard, J. M., Zeng, M. Y., Caruso, R. & Nunez, G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 279, 70\u201389 (2017).","journal-title":"Immunol. Rev."},{"key":"16222_CR4","first-page":"430","volume":"11","author":"U Hofer","year":"2013","unstructured":"Hofer, U. Microbiome: a mucus colonizer manages host metabolism. Nat. Rev. Microbiol. 11, 430\u2013431 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"16222_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fimmu.2017.00605","volume":"8","author":"LMS Pereira","year":"2017","unstructured":"Pereira, L. M. S., Gomes, S. T. M., Ishak, R. & Vallinoto, A. C. R. Regulatory T cell and Forkhead Box Protein 3 as modulators of immune homeostasis. Front. Immunol. 8, 605 (2017).","journal-title":"Front. Immunol."},{"key":"16222_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569\u2013573 (2013).","journal-title":"Science"},{"key":"16222_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.chom.2010.08.004","volume":"8","author":"WS Garrett","year":"2010","unstructured":"Garrett, W. S. et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8, 292\u2013300 (2010).","journal-title":"Cell Host Microbe"},{"key":"16222_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.4049\/jimmunol.1002021","volume":"186","author":"MM Zaragoza","year":"2011","unstructured":"Zaragoza, M. M. et al. Persistence of gut mucosal innate immune defenses by enteric alpha-defensin expression in the simian immunodeficiency virus model of AIDS. J. Immunol. 186, 1589\u20131597 (2011).","journal-title":"J. Immunol."},{"key":"16222_CR9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/infdis\/jit547","volume":"209","author":"K Allers","year":"2014","unstructured":"Allers, K. et al. Macrophages accumulate in the gut mucosa of untreated HIV-infected patients. J. Infect. Dis. 209, 739\u2013748 (2014).","journal-title":"J. Infect. Dis."},{"key":"16222_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/QAD.0000000000000511","volume":"29","author":"M Somsouk","year":"2015","unstructured":"Somsouk, M. et al. Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS 29, 43\u201351 (2015).","journal-title":"AIDS"},{"key":"16222_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.virol.2013.08.018","volume":"446","author":"SM Tugizov","year":"2013","unstructured":"Tugizov, S. M. et al. HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology 446, 378\u2013388 (2013).","journal-title":"Virology"},{"key":"16222_CR12","doi-asserted-by":"publisher","first-page":"e1000295","DOI":"10.1371\/journal.ppat.1000295","volume":"5","author":"D Favre","year":"2009","unstructured":"Favre, D. et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 5, e1000295 (2009).","journal-title":"PLoS Pathog."},{"key":"16222_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ebiom.2018.03.024","volume":"30","author":"CP Neff","year":"2018","unstructured":"Neff, C. P. et al. Fecal microbiota composition drives immune activation in HIV-infected individuals. EBioMedicine 30, 192\u2013202 (2018).","journal-title":"EBioMedicine"},{"key":"16222_CR14","doi-asserted-by":"publisher","unstructured":"Bourke, C. D. et al. Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation. Sci. Transl. Med. 11, https:\/\/doi.org\/10.1126\/scitranslmed.aav0537 (2019).","DOI":"10.1126\/scitranslmed.aav0537"},{"key":"16222_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/infdis\/jiu409","volume":"211","author":"DM Dinh","year":"2015","unstructured":"Dinh, D. M. et al. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis. 211, 19\u201327 (2015).","journal-title":"J. Infect. Dis."},{"key":"16222_CR16","doi-asserted-by":"publisher","first-page":"193ra191","DOI":"10.1126\/scitranslmed.3006438","volume":"5","author":"I Vujkovic-Cvijin","year":"2013","unstructured":"Vujkovic-Cvijin, I. et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med. 5, 193ra191 (2013).","journal-title":"Sci. Transl. Med."},{"key":"16222_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.chom.2016.02.011","volume":"19","author":"CL Monaco","year":"2016","unstructured":"Monaco, C. L. et al. Altered virome and bacterial microbiome in human immunodeficiency virus-associated acquired immunodeficiency syndrome. Cell Host Microbe 19, 311\u2013322 (2016).","journal-title":"Cell Host Microbe"},{"key":"16222_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.chom.2013.08.006","volume":"14","author":"CA Lozupone","year":"2013","unstructured":"Lozupone, C. A. et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe 14, 329\u2013339 (2013).","journal-title":"Cell Host Microbe"},{"key":"16222_CR19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3389\/fmicb.2018.01451","volume":"9","author":"W Lu","year":"2018","unstructured":"Lu, W. et al. Association between gut microbiota and CD4 recovery in HIV-1 infected patients. Front. Microbiol. 9, 1451 (2018).","journal-title":"Front. Microbiol."},{"key":"16222_CR20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/mi.2013.116","volume":"7","author":"SM Dillon","year":"2014","unstructured":"Dillon, S. M. et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 7, 983\u2013994 (2014).","journal-title":"Mucosal Immunol."},{"key":"16222_CR21","doi-asserted-by":"publisher","first-page":"e1003829","DOI":"10.1371\/journal.ppat.1003829","volume":"10","author":"EA Mutlu","year":"2014","unstructured":"Mutlu, E. A. et al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog. 10, e1003829 (2014).","journal-title":"PLoS Pathog."},{"key":"16222_CR22","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/mi.2014.107","volume":"8","author":"JF Vazquez-Castellanos","year":"2015","unstructured":"Vazquez-Castellanos, J. F. et al. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals. Mucosal Immunol. 8, 760\u2013772 (2015).","journal-title":"Mucosal Immunol."},{"key":"16222_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep30673","volume":"6","author":"Z Ling","year":"2016","unstructured":"Ling, Z. et al. Alterations in the fecal microbiota of patients with HIV-1 infection: an observational study in a chinese population. Sci. Rep. 6, 30673 (2016).","journal-title":"Sci. Rep."},{"key":"16222_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2016.01.032","volume":"5","author":"M Noguera-Julian","year":"2016","unstructured":"Noguera-Julian, M. et al. Gut microbiota linked to sexual preference and HIV infection. EBioMedicine 5, 135\u2013146 (2016).","journal-title":"EBioMedicine"},{"key":"16222_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0580-7","volume":"6","author":"AJS Armstrong","year":"2018","unstructured":"Armstrong, A. J. S. et al. An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men. Microbiome 6, 198 (2018).","journal-title":"Microbiome"},{"key":"16222_CR26","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/mi.2016.97","volume":"10","author":"CF Kelley","year":"2017","unstructured":"Kelley, C. F. et al. The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and prevention. Mucosal Immunol. 10, 996\u20131007 (2017).","journal-title":"Mucosal Immunol."},{"key":"16222_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz258","author":"SA Tuddenham","year":"2019","unstructured":"Tuddenham, S. A. et al. The impact of HIV infection on gut microbiota alpha-diversity: an individual level meta-analysis. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciz258 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"16222_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1574-6941.2002.tb00942.x","volume":"40","author":"J Loubinoux","year":"2002","unstructured":"Loubinoux, J., Bronowicki, J. P., Pereira, I. A., Mougenel, J. L. & Faou, A. E. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol. Ecol. 40, 107\u2013112 (2002).","journal-title":"FEMS Microbiol. Ecol."},{"key":"16222_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.chom.2016.03.004","volume":"19","author":"F Rivera-Chavez","year":"2016","unstructured":"Rivera-Chavez, F. et al. Depletion of butyrate-producing clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella. Cell Host Microbe 19, 443\u2013454 (2016).","journal-title":"Cell Host Microbe"},{"key":"16222_CR30","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.cell.2018.10.029","volume":"175","author":"P Vangay","year":"2018","unstructured":"Vangay, P. et al. US immigration westernizes the human gut microbiome. Cell 175, 962\u2013972.e910 (2018).","journal-title":"Cell"},{"key":"16222_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/ismej.2012.88","volume":"7","author":"DH Parks","year":"2013","unstructured":"Parks, D. H. & Beiko, R. G. Measures of phylogenetic differentiation provide robust and complementary insights into microbial communities. ISME J. 7, 173\u2013183 (2013).","journal-title":"ISME J."},{"key":"16222_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11904-019-00441-w","volume":"16","author":"I Vujkovic-Cvijin","year":"2019","unstructured":"Vujkovic-Cvijin, I. & Somsouk, M. HIV and the gut microbiota: composition, consequences, and avenues for amelioration. Curr. HIV\/AIDS Rep. 16, 204\u2013213 (2019).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"16222_CR33","doi-asserted-by":"publisher","first-page":"570","DOI":"10.7326\/0003-4819-130-7-199904060-00005","volume":"130","author":"V Miller","year":"1999","unstructured":"Miller, V. et al. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study. Ann. Intern. Med. 130, 570\u2013577 (1999).","journal-title":"Ann. Intern. Med."},{"key":"16222_CR34","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1001\/jama.286.20.2568","volume":"286","author":"RS Hogg","year":"2001","unstructured":"Hogg, R. S. et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 286, 2568\u20132577 (2001).","journal-title":"JAMA"},{"key":"16222_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/hiv.12315","volume":"17","author":"LJ Rasmussen","year":"2016","unstructured":"Rasmussen, L. J. et al. Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study. HIV Med. 17, 350\u2013357 (2016).","journal-title":"HIV Med."},{"key":"16222_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy966","author":"M Hoenigl","year":"2018","unstructured":"Hoenigl, M. et al. Soluble urokinase plasminogen activator receptor (suPAR) is predictive of Non-AIDS events during antiretroviral therapy-mediated viral suppression. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciy966 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"16222_CR37","doi-asserted-by":"publisher","first-page":"e0155100","DOI":"10.1371\/journal.pone.0155100","volume":"11","author":"B Grund","year":"2016","unstructured":"Grund, B. et al. Relevance of interleukin-6 and D-dimer for serious non-AIDS morbidity and death among HIV-positive adults on suppressive antiretroviral therapy. PLoS ONE 11, e0155100 (2016).","journal-title":"PLoS ONE"},{"key":"16222_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11904-009-0038-4","volume":"7","author":"S Desai","year":"2010","unstructured":"Desai, S. & Landay, A. Early immune senescence in HIV disease. Curr. HIV\/AIDS Rep. 7, 4\u201310 (2010).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"16222_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179\u2013185 (2012).","journal-title":"Nature"},{"key":"16222_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41385-018-0083-7","volume":"12","author":"Y Guillen","year":"2019","unstructured":"Guillen, Y. et al. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 12, 232\u2013246 (2019).","journal-title":"Mucosal Immunol."},{"key":"16222_CR41","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng, L., Li, Z. R., Green, R. S., Holzman, I. R. & Lin, J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 139, 1619\u20131625 (2009).","journal-title":"J. Nutr."},{"key":"16222_CR42","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.immuni.2009.10.001","volume":"31","author":"G Oldenhove","year":"2009","unstructured":"Oldenhove, G. et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31, 772\u2013786 (2009).","journal-title":"Immunity"},{"key":"16222_CR43","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.4049\/jimmunol.170.8.3939","volume":"170","author":"C Mottet","year":"2003","unstructured":"Mottet, C., Uhlig, H. H. & Powrie, F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170, 3939\u20133943 (2003).","journal-title":"J. Immunol."},{"key":"16222_CR44","doi-asserted-by":"publisher","first-page":"e00889","DOI":"10.1128\/mBio.00889-14","volume":"5","author":"M Vital","year":"2014","unstructured":"Vital, M., Howe, A. C. & Tiedje, J. M. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio 5, e00889 (2014).","journal-title":"MBio"},{"key":"16222_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep43741","volume":"7","author":"S Pinto-Cardoso","year":"2017","unstructured":"Pinto-Cardoso, S. et al. Fecal bacterial communities in treated HIV infected individuals on two antiretroviral regimens. Sci. Rep. 7, 43741 (2017).","journal-title":"Sci. Rep."},{"key":"16222_CR46","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/MCG.0b013e31819194b0","volume":"43","author":"JP Derikx","year":"2009","unstructured":"Derikx, J. P. et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J. Clin. Gastroenterol. 43, 727\u2013733 (2009).","journal-title":"J. Clin. Gastroenterol."},{"key":"16222_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/mi.2007.1","volume":"1","author":"JM Brenchley","year":"2008","unstructured":"Brenchley, J. M. & Douek, D. C. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 1, 23\u201330 (2008).","journal-title":"Mucosal Immunol."},{"key":"16222_CR48","doi-asserted-by":"publisher","first-page":"e1001052","DOI":"10.1371\/journal.ppat.1001052","volume":"6","author":"JD Estes","year":"2010","unstructured":"Estes, J. D. et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 6, e1001052 (2010).","journal-title":"PLoS Pathog."},{"key":"16222_CR49","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365\u20131371 (2006).","journal-title":"Nat. Med."},{"key":"16222_CR50","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/597476","volume":"199","author":"W Jiang","year":"2009","unstructured":"Jiang, W. et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 199, 1177\u20131185 (2009).","journal-title":"J. Infect. Dis."},{"key":"16222_CR51","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1158\/1055-9965.EPI-11-0037","volume":"20","author":"EC Breen","year":"2011","unstructured":"Breen, E. C. et al. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Cancer Epidemiol. Biomark. Prev. 20, 1303\u20131314 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"16222_CR52","doi-asserted-by":"publisher","first-page":"e44454","DOI":"10.1371\/journal.pone.0044454","volume":"7","author":"DA Duprez","year":"2012","unstructured":"Duprez, D. A. et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS ONE 7, e44454 (2012).","journal-title":"PLoS ONE"},{"key":"16222_CR53","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2337\/dc10-0633","volume":"33","author":"TT Brown","year":"2010","unstructured":"Brown, T. T., Tassiopoulos, K., Bosch, R. J., Shikuma, C. & McComsey, G. A. Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care 33, 2244\u20132249 (2010).","journal-title":"Diabetes Care"},{"key":"16222_CR54","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/infdis\/jiv194","volume":"212","author":"TT Brown","year":"2015","unstructured":"Brown, T. T. et al. Changes in bone mineral density after initiation of antiretroviral treatment with tenofovir disoproxil fumarate\/emtricitabine plus atazanavir\/ritonavir, darunavir\/ritonavir, or raltegravir. J. Infect. Dis. 212, 1241\u20131249 (2015).","journal-title":"J. Infect. Dis."},{"key":"16222_CR55","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1378\/chest.14-0543","volume":"146","author":"EF Attia","year":"2014","unstructured":"Attia, E. F. et al. Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest 146, 1543\u20131553 (2014).","journal-title":"Chest"},{"key":"16222_CR56","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1161\/STROKEAHA.112.664094","volume":"43","author":"A Edsfeldt","year":"2012","unstructured":"Edsfeldt, A. et al. Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque. Stroke 43, 3305\u20133312 (2012).","journal-title":"Stroke"},{"key":"16222_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/srep39481","volume":"6","author":"W Ni","year":"2016","unstructured":"Ni, W. et al. Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis. Sci. Rep. 6, 39481 (2016).","journal-title":"Sci. Rep."},{"key":"16222_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2796.2011.02363.x","volume":"270","author":"R Huttunen","year":"2011","unstructured":"Huttunen, R. et al. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J. Intern Med. 270, 32\u201340 (2011).","journal-title":"J. Intern Med."},{"key":"16222_CR59","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1128\/IAI.68.4.2156-2160.2000","volume":"68","author":"PE Dekkers","year":"2000","unstructured":"Dekkers, P. E., ten Hove, T., te Velde, A. A., van Deventer, S. J. & van Der Poll, T. Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia. Infect. Immun. 68, 2156\u20132160 (2000).","journal-title":"Infect. Immun."},{"key":"16222_CR60","doi-asserted-by":"publisher","first-page":"e98923","DOI":"10.1371\/journal.pone.0098923","volume":"9","author":"W Gozdzik","year":"2014","unstructured":"Gozdzik, W. et al. Unchanged plasma levels of the soluble urokinase plasminogen activator receptor in elective coronary artery bypass graft surgery patients and cardiopulmonary bypass use. PLoS ONE 9, e98923 (2014).","journal-title":"PLoS ONE"},{"key":"16222_CR61","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1089\/aid.2010.0252","volume":"27","author":"O Begay","year":"2011","unstructured":"Begay, O. et al. Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res Hum. Retroviruses 27, 1019\u20131024 (2011).","journal-title":"AIDS Res Hum. Retroviruses"},{"key":"16222_CR62","doi-asserted-by":"publisher","first-page":"E9105","DOI":"10.1073\/pnas.1711596114","volume":"114","author":"JL Mark Welch","year":"2017","unstructured":"Mark Welch, J. L., Hasegawa, Y., McNulty, N. P., Gordon, J. I. & Borisy, G. G. Spatial organization of a model 15-member human gut microbiota established in gnotobiotic mice. Proc. Natl Acad. Sci. USA 114, E9105\u2013E9114 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16222_CR63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fgene.2015.00081","volume":"6","author":"LE Tailford","year":"2015","unstructured":"Tailford, L. E., Crost, E. H., Kavanaugh, D. & Juge, N. Mucin glycan foraging in the human gut microbiome. Front. Genet. 6, 81 (2015).","journal-title":"Front. Genet."},{"key":"16222_CR64","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25, 1096\u20131103 (2019).","journal-title":"Nat. Med."},{"key":"16222_CR65","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nature25973","volume":"555","author":"D Rothschild","year":"2018","unstructured":"Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210\u2013215 (2018).","journal-title":"Nature"},{"key":"16222_CR66","doi-asserted-by":"publisher","first-page":"e2006842","DOI":"10.1371\/journal.pbio.2006842","volume":"16","author":"AW Brooks","year":"2018","unstructured":"Brooks, A. W., Priya, S., Blekhman, R. & Bordenstein, S. R. Gut microbiota diversity across ethnicities in the United States. PLoS Biol. 16, e2006842 (2018).","journal-title":"PLoS Biol."},{"key":"16222_CR67","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"16222_CR68","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/infdis\/jiz042","volume":"219","author":"O Sortino","year":"2019","unstructured":"Sortino, O. et al. The effects of recombinant human lactoferrin on immune activation and the intestinal microbiome among persons living with human immunodeficiency virus and receiving antiretroviral therapy. J. Infect. Dis. 219, 1963\u20131968 (2019).","journal-title":"J. Infect. Dis."},{"key":"16222_CR69","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/19490976.2017.1334034","volume":"8","author":"I Vujkovic-Cvijin","year":"2017","unstructured":"Vujkovic-Cvijin, I. et al. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals. Gut Microbes 8, 440\u2013450 (2017).","journal-title":"Gut Microbes"},{"key":"16222_CR70","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/mi.2015.92","volume":"9","author":"TW Glavan","year":"2016","unstructured":"Glavan, T. W. et al. Gut immune dysfunction through impaired innate pattern recognition receptor expression and gut microbiota dysbiosis in chronic SIV infection. Mucosal Immunol. 9, 677\u2013688 (2016).","journal-title":"Mucosal Immunol."},{"key":"16222_CR71","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.celrep.2015.10.026","volume":"13","author":"I Vujkovic-Cvijin","year":"2015","unstructured":"Vujkovic-Cvijin, I. et al. Gut-resident Lactobacillus abundance associates with IDO1 inhibition and Th17 dynamics in SIV-infected Macaques. Cell Rep. 13, 1589\u20131597 (2015).","journal-title":"Cell Rep."},{"key":"16222_CR72","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/mi.2014.128","volume":"8","author":"Z Klase","year":"2015","unstructured":"Klase, Z. et al. Dysbiotic bacteria translocate in progressive SIV infection. Mucosal Immunol. 8, 1009\u20131020 (2015).","journal-title":"Mucosal Immunol."},{"key":"16222_CR73","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.chom.2013.08.005","volume":"14","author":"AH Moeller","year":"2013","unstructured":"Moeller, A. H. et al. SIV-induced instability of the chimpanzee gut microbiome. Cell Host Microbe 14, 340\u2013345 (2013).","journal-title":"Cell Host Microbe"},{"key":"16222_CR74","doi-asserted-by":"publisher","unstructured":"Barbian, H. J. et al. Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees. Am. J. Primatol. 80, https:\/\/doi.org\/10.1002\/ajp.22515 (2018).","DOI":"10.1002\/ajp.22515"},{"key":"16222_CR75","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.chom.2016.02.010","volume":"19","author":"SA Handley","year":"2016","unstructured":"Handley, S. A. et al. SIV infection-mediated changes in gastrointestinal bacterial microbiome and virome are associated with immunodeficiency and prevented by vaccination. Cell Host Microbe 19, 323\u2013335 (2016).","journal-title":"Cell Host Microbe"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16222-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16222-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16222-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:06:24Z","timestamp":1670259984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16222-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16222"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16222-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]},"assertion":[{"value":"1 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PR reports independent scientific grant support from Gilead Sciences, Merck & Co, and ViiV Healthcare through his institution; scientific advisory board participation for Gilead Sciences, ViiV Healthcare, Merck & Co., and Teva Pharmaceutical Industries Ltd., for which his institution has received remuneration. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2448"}}